Pierre Fabre and MHB collaborate on plant projects

By staff reporter

- Last updated on GMT

Related tags: Nutrition, Medicine, Corporation

France-based Laboratoires Pierre Fabre has announced an agreement
with Canadian bioresearcher Millenia Hope Biopharma (MHB), which
may yield new plant-based products for use by the nutraceuticals
industry.

The companies have called their collaboration "important"​, but a spokesperson for Pierre Fabre was unable to revealed details about how exactly it will work due to a confidentiality agreement.

Nonetheless, a collaboration between the two organisations, both of which have impressive resources for the exploitation and commercialisation of plant for health and cosmetic uses, could help expand the plant-based toolkit that nutraceutical industry has at its disposal when designing health enriching products.

Pierre Fabre, located in Castries, focuses on the development of plant-derived health, ethical and dermo-cosmetic products. Its efforts in the field of oncology account for 50 per cent of its R&D spend, with the remainder devoted to the central nervous system, cardiology, internal medicine/urology, and dermatology.

MHB, meanwhile, has devoted more than US$25m to developing its Phytomics Technologies, which includes a collection of purified phytochemical fractions for use by the nutraceutical, pharmaceutical and cosmetics industries.

MHB said that it is in the midst of commercialising several projects with leading multinational corporations.

Related topics: Polyphenols

Related news

Related products

Follow us

Products

View more

Webinars